BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24976364)

  • 1. Eicosapentaenoic acid/arachidonic acid ratio as a possible link between non-alcoholic fatty liver disease and cardiovascular disease.
    Ishitobi T; Hyogo H; Kan H; Hiramatsu A; Arihiro K; Aikata H; Chayama K
    Hepatol Res; 2015 May; 45(5):533-9. PubMed ID: 24976364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerobic Physical Activity and a Low Glycemic Diet Reduce the AA/EPA Ratio in Red Blood Cell Membranes of Patients with NAFLD.
    Tutino V; De Nunzio V; Caruso MG; Bonfiglio C; Franco I; Mirizzi A; De Leonardis G; Cozzolongo R; Giannuzzi V; Giannelli G; Notarnicola M; Osella AR
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30217048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study.
    Ninomiya T; Nagata M; Hata J; Hirakawa Y; Ozawa M; Yoshida D; Ohara T; Kishimoto H; Mukai N; Fukuhara M; Kitazono T; Kiyohara Y
    Atherosclerosis; 2013 Dec; 231(2):261-7. PubMed ID: 24267237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients.
    Shoji T; Kakiya R; Hayashi T; Tsujimoto Y; Sonoda M; Shima H; Mori K; Fukumoto S; Tahara H; Shioi A; Tabata T; Emoto M; Nishizawa Y; Inaba M
    Am J Kidney Dis; 2013 Sep; 62(3):568-76. PubMed ID: 23602192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eicosapentaenoic Acid and Prevalence of Cardiovascular Disease in Hemodialysis Patients.
    Honda T; Kishi S; Furukawa E; Ambe H; Kurata Y; Ichikawa M; Aoe M; Ohara K; Furuse S; Saito K; Nishio K; Masaki K; Kano T; Mise N
    Ther Apher Dial; 2018 Oct; 22(5):514-518. PubMed ID: 29987872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Serum Eicosapentaenoic Acid to Arachidonic Acid Ratio and Atherosclerotic Risk Factors in Patients With Peripheral Artery Disease.
    Nishibe T; Dardik A; Nishibe M; Kano M; Matsumoto R; Nakano Y; Maekawa K; Irikata Y; Ogino H; Ono S; Koizumi J
    Vasc Endovascular Surg; 2021 Feb; 55(2):112-116. PubMed ID: 33073735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal study of the association of the eicosapentaenoic acid/arachidonic acid ratio derived from fish consumption with the serum lipid levels: a pilot study.
    Tani S; Matsuo R; Matsumoto N
    Heart Vessels; 2019 Jan; 34(1):189-196. PubMed ID: 30014269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in the eicosapentaenoic acid-arachidonic acid ratio associated with age in acute myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Nakabayashi K; Jujo K; Furuki Y; Ishida I; Ando H; Shimizu M; Hagiwara N; Saito K
    Heart Vessels; 2019 May; 34(5):755-762. PubMed ID: 30430295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of Eicosapentaenoic Acid to Arachidonic Acid Ratio on Long-term Cardiovascular Events Following Percutaneous Coronary Intervention.
    Niwa K; Tanaka A; Funakubo H; Otsuka S; Yoshioka N; Kudo N; Tobe A; Sakakibara K; Miki Y; Kataoka T; Furusawa K; Ishii H; Murohara T
    Intern Med; 2021 Dec; 60(24):3865-3871. PubMed ID: 34148960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations With Eicosapentaenoic Acid to Arachidonic Acid Ratio and Mortality in Hospitalized Heart Failure Patients.
    Watanabe S; Yoshihisa A; Kanno Y; Takiguchi M; Yokokawa T; Sato A; Miura S; Shimizu T; Abe S; Sato T; Suzuki S; Oikawa M; Sakamoto N; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
    J Card Fail; 2016 Dec; 22(12):962-969. PubMed ID: 27138463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cancer death in a Japanese community: The Hisayama Study.
    Nagata M; Hata J; Hirakawa Y; Mukai N; Yoshida D; Ohara T; Kishimoto H; Kawano H; Kitazono T; Kiyohara Y; Ninomiya T
    J Epidemiol; 2017 Dec; 27(12):578-583. PubMed ID: 28669629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound analysis of gray-scale median value of carotid plaques is a useful reference index for cerebro-cardiovascular events in patients with type 2 diabetes.
    Ariyoshi K; Okuya S; Kunitsugu I; Matsunaga K; Nagao Y; Nomiyama R; Takeda K; Tanizawa Y
    J Diabetes Investig; 2015 Jan; 6(1):91-7. PubMed ID: 25621138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of smoking history on the association between Eicosapentaenoic acid to arachidonic acid ratio and acute coronary syndrome: A multicenter cross-sectional study.
    Nishizaki Y; Shimada K; Tani S; Ogawa T; Ando J; Takahashi M; Yamamoto M; Shinozaki T; Miyazaki T; Miyauchi K; Nagao K; Hirayama A; Yoshimura M; Komuro I; Nagai R; Daida H
    Tob Induc Dis; 2018; 16():08. PubMed ID: 31516408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in the ratio of eicosapentaenoic acid to arachidonic acid in an inland prefecture, Tochigi: Tochigi Ryomo EPA/AA Trial in Coronary Artery Disease (TREAT-CAD).
    Kitagawa Y; Abe S; Toyoda S; Watanabe S; Ebisawa K; Murakami Y; Takahashi T; Sugimura H; Taguchi I; Inoue T
    Intern Med; 2014; 53(3):177-82. PubMed ID: 24492684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between the serum eicosapentanoic acid-to-arachidonic acid ratio and the severity of cerebral white matter hyperintensities in older adults with memory disorder.
    Nagai K; Koshiba H; Shibata S; Matsui T; Kozaki K
    Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():48-52. PubMed ID: 26671157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A defect in the activities of Δ and Δ desaturases and pro-resolution bioactive lipids in the pathobiology of non-alcoholic fatty liver disease.
    Das UN
    World J Diabetes; 2011 Nov; 2(11):176-88. PubMed ID: 22087354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease.
    Nelson JR; Raskin S
    Postgrad Med; 2019 May; 131(4):268-277. PubMed ID: 31063407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age Stratification and Impact of Eicosapentaenoic Acid and Docosahexaenoic Acid to Arachidonic Acid Ratios in Ischemic Stroke Patients.
    Ueno Y; Tanaka R; Yamashiro K; Miyamoto N; Hira K; Kurita N; Sakurai M; Urabe T; Shimada K; Miyazaki T; Daida H; Hattori N
    J Atheroscler Thromb; 2018 Jul; 25(7):593-605. PubMed ID: 29199200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ratio of eicosapentaenoic acid to arachidonic acid is a critical risk factor for acute coronary syndrome in middle-aged older patients as well as younger adult patients.
    Serikawa T; Miura S; Okabe M; Hongo H; Tokutome M; Yoshikawa T; Takesue K; Adachi S; Osaka K; Matsukawa R; Yanagi D; Nozoe M; Kozai T; Hironaga K; Saku K; Yamamoto Y
    J Cardiol; 2014 Jan; 63(1):35-40. PubMed ID: 23993904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LC/ESI-MS/MS method for determination of salivary eicosapentaenoic acid concentration to arachidonic acid concentration ratio.
    Ogawa S; Tomaru K; Matsumoto N; Watanabe S; Higashi T
    Biomed Chromatogr; 2016 Jan; 30(1):29-34. PubMed ID: 25620210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.